Omics Tools and MDx Stocks Sluggish in April; More than Half of Companies See Share Prices Drop | GenomeWeb

NEW YORK (GenomeWeb News) – More than half of the companies operating in the omics tools and molecular diagnostics space saw their stock prices drop in April, resulting in a sluggish GenomeWeb Daily News Index for the month.

Of the 29 firms in the GWDN Index, 16 declined during the past month, and overall the index inched up less than 1 percent. It trailed the Dow Jones Industrial Average and the Nasdaq, which grew a little less than 2 percent each, as well as the Nasdaq Biotech Index, which gained almost 8 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: comprehensive analysis of somatic mutations in breast cancer, and more.

A number of studies indicate that genes might influence political beliefs, Scientific American Mind reports.

Craig Venter's Human Longevity is deeply phenotyping individuals and capturing their genetic profiles to explore aging.

The San Francisco Business Times examines Verily's latest hires.